The government has decided to set up a National Vaccine Fund as a dedicated, professionally managed investment vehicle ...

As clinical trials race against time, especially during global health emergencies, data-driven patient enrollment has become ...

Nexsen Limited (ASX:NXN) has announced the commencement of formal engagement with the United States Food and Drug ...

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

AI emerged as a key differentiator in accelerating development timelines and enhancing clinical operations. Decentralized ...

The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

After a tumultuous year, experts call for stability while anticipating the first fruits of policies intended to expedite ...

Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...

Global Life Science Consulting Services Market OverviewThe global life science consulting services market is projected to ...

Prevention, screening, and vaccination are vital for managing infection risk during pregnancy due to altered maternal immunity.

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...